The low dose is doing its job, priming your system for what comes next
Brain receptors promote feelings of satiety and reduce food cravings, helping to manage caloric intake

Research has identified these alarming vision-related risks associated with GLP-1 medications: Sudden irreversible vision loss: NAION strikes without warning, often discovered upon waking, causing blurry or dim vision that progresses to immediate and permanent partial or complete blindness in the affected eye with no possibility of restoration Elevated risk across multiple studies: Beyond the Harvard findings showing 4-7 fold increased risk, a University of Southern Denmark study examining over 424,000 patients found weekly semaglutide users faced 2.19 times higher NAION risk European regulatory recognition: In June 2025, the European Medicines Agency officially recognized NAION as a possible side effect of semaglutide medications, marking formal acknowledgment by international regulators Complete absence of treatment options: Medical science currently offers no cure, no effective treatment, and no way to reverse NAION-related vision damage, leaving patients with permanent disability The permanent and irreversible nature of NAION-related optic nerve damage distinguishes these injuries from other complications that may resolve after discontinuing medication

In vitro, BPC-157 has shown activity in models involving muscle, tendon, ligament, and epithelial cell recovery, as well as studies examining oxidative stress and inflammatory signaling pathways
Mavrogiorgos says antibiotics are essential in particular for serious bacterial infections that affect the function of vital organs and cause sepsis
Tip: If taking zinc, on an empty stomach, causes nausea, we recommend taking it with a meal